Pegylated leptin antagonist is a potent orexigenic agent: Preparation and mechanism of activity

Endocrinology

Volumn 150, Issue 7, 2009, Pages 3083-3091

  Elinav, Eran ^a   Niv Spector, Leonora ^b   Katz, Meirav ^a   Price, Tulin O ^c   Ali, Mohammed ^a   Yacobovitz, Michal ^b   Solomon, Gili ^b   Reicher, Shay ^b   Lynch, Jessica L ^c   Halpern, Zamir ^a   Banks, William A ^c   Gertler, Arieh ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; APPETITE STIMULANT; CHOLESTEROL; LEPTIN; LEPTIN ANTAGONIST; LEPTIN ANTAGONIST I 131; LEPTIN I 131; PEGLEPTIN ANTAGONIST; PEGLEPTIN ANTAGONIST I 131; RADIOPHARMACEUTICAL AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BLOOD BRAIN BARRIER; CACHEXIA; CHEMICAL PROCEDURES; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TRANSPORT; FEMALE; FOOD INTAKE; HORMONE DEFICIENCY; IMMUNE RESPONSE; INCREASED APPETITE; LIPID STORAGE; MALE; MESENTERY; MOUSE; NONHUMAN; PEGYLATION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; BLOOD-BRAIN BARRIER; EATING; FEMALE; HUMANS; LEPTIN; MALE; POLYETHYLENE GLYCOLS; WEIGHT GAIN;

EID: 67649665611     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1706     Document Type: Article

References (55)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432 (Pubitemid 24365442)
2. Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A 2007 Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc Med 17:206-211 (Pubitemid 47089011)
3. Peelman F, Waelput W, Iserentant H, Lavens D, Eyckerman S, Zabeau L, Tavernier J 2004 Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lipid Res 43:283-301 (Pubitemid 38952616)
4. La Cava A, Matarese G 2004 The weight of leptin in immunity. Nat Rev Immunol 4:371-379 (Pubitemid 38649279)
5. Matarese G, Moschos S, Mantzoros CS 2005 Leptin in immunology. J Immunol 174:3137-3142 (Pubitemid 40354011)
6. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, Fukuda T, Yamashina S, Kitamura T, Sato N 2002 Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 122:1399-1410 (Pubitemid 34465182)
7. Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A, MeguidMM2004 Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 7:427-434 (Pubitemid 40340650)
8. Mak RH, Cheung W, Cone RD, Marks DL 2006 Mechanisms of disease: cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol 2:527-534
9. Torsello A, Brambilla F, Tamiazzo L, Bulgarelli I, Rapetti D, Bresciani E, Locatelli V 2007 Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa. J Endocrinol Invest 30:962-976
10. Elinav E, Ali M, Bruck R, Brazowsky E, Phillips A, Shapira Y, Katz M, Solomon G, Halpern Z, Gertler A 2009 Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function. Hepatology 49:278-286
11. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D 1979 Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 16:251-270 (Pubitemid 10208487)
12. Haffner D, Schaefer F, Girard J, Ritz E, Mehls O 1994 Metabolic clearance of recombinanthumangrowth hormone in health and chronic renal failure. J Clin Invest 93:1163-1171 (Pubitemid 24087171)
13. Fuertges F, Abuchowski A 1990 The clinical efficacy of poly(ethylene glycol)- modified proteins. J Controlled Release 11:139-148 (Pubitemid 20070092)
14. Bailon P, Berthold W 1998 Polyethylene glycol-conjugated pharmaceutical proteins. Pharm Sci Technol Today 1:352-356 (Pubitemid 28526964)
15. Clark R, Olson K, Fuh G, Marian M, Mortensen D, Teshima G, Chang S, Chu H, Mukku V, Canova-Davis E, Somers T, Cronin M, Winkler M, Wells JA 1996 Long-acting growth hormones produced by conjugation with polyethylene glycol. J Biol Chem 271:21969-21977 (Pubitemid 26303822)
16. Raver N, Gussakovsky EE, Keisler DH, Krishna R, Mistry J, Gertler A 2000 Preparation of recombinant bovine, porcine, and porcine W4R/R5K leptins and comparison of their activity and immunoreactivity with ovine, chicken, and human leptins. Protein Expr Purif 19:30-40 (Pubitemid 30387891)
17. Niv-Spector L, Gonen-Berger D, Gourdou I, Biener E, Gussakovsky EE, Benomar Y, Ramanujan KV, Taouis M, Herman B, Callebaut I, Djiane J, Gertler A 2005 Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists. Biochem J 391:221-230 (Pubitemid 41532418)
18. Mystkowski P, Shankland E, Schreyer SA, LeBoeuf RC, Schwartz RS, Cummings DE, Kushmerick M, Schwartz MW 2000 Validation of whole-body magnetic resonance spectroscopy as a tool to assess murine body composition. Int J Obes Relat Metab Disord 24:719-724 (Pubitemid 30339269)
19. Patlak CS, Blasberg RG, Fenstermacher JD 1983 Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1-7
20. Blasberg RG, Patlak CS, Fenstermacher JD 1983 Selection of experimental conditions for the accurate determination of blood-brain transfer constants from single-time experiments: a theoretical analysis. J Cereb Blood Flow Metab 3:215-225
21. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM 1996 Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311 (Pubitemid 26124406)
22. Triguero D, Buciak J, Pardridge WM 1990 Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 54:1882-1888 (Pubitemid 20173337)
23. Gutierrez EG, Banks WA, Kastin AJ 1993 Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 47:169-176 (Pubitemid 23284281)
24. Banks WA, Kastin AJ, Fischman AJ, Coy DH, Strauss SL 1986 Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. Am J Physiol 251:E477-E482 (Pubitemid 17183791)
25. Elinav E, Waks T, Eshhar Z 2008 Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Gastroenterology 134:2014-2024 (Pubitemid 351783252)
26. Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF 2002 Structural and biological characterization of pegylated recombinant interferon α-2b and its therapeutic implications. Adv Drug Deliv Rev 54:547-570 (Pubitemid 34618512)
27. Bailon P, Palleroni A, Schaffer CA, Spence CL, Fung WJ, Porter JE, EhrlichGK, Pan W, Xu ZX, Modi MW, Farid A, Berthold W, Graves M 2001 Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C. Bioconjug Chem 12:195-202 (Pubitemid 32235471)
28. Myers MG, Cowley MA, Munzberg H 2008 Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537-556 (Pubitemid 351738191)
29. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE 2002 The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005-1015 (Pubitemid 34438343)
30. Johannsson G, Karlsson C, Lonn L, Marin P, Bjorntorp P, Sjostrom L, Carlsson B, Carlsson LM, Bengtsson BA 1998 Serum leptin concentration and insulin sensitivity in men with abdominal obesity. Obes Res 6:416-421 (Pubitemid 128679691)
31. Sudi KM, Gallistl S, Tafeit E, Moller R, Borkenstein MH 2000 The relationship between different subcutaneous adipose tissue layers, fat mass and leptin in obese children and adolescents. J Pediatr Endocrinol Metab 13:505-512 (Pubitemid 30253142)
32. Tai ES, Lau TN, Ho SC, Fok AC, Tan CE 2000 Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin. Int J Obes Relat Metab Disord 24:751-757 (Pubitemid 30339273)
33. Misra A, Vikram NK 2003 Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 19:457-466 34.
34. Banks WA 2004 Are the extracellular [correction of extracellular] pathways a conduit for the delivery of therapeutics to the brain? Curr Pharm Des 10: 1365-1370
35. Banks WA 2006 The CNS as a target for peptides and peptide-based drugs. Expert Opin Drug Deliv 3:707-712 (Pubitemid 44781843)
36. Banks WA 2004 The many lives of leptin. Peptides 25:331-338 (Pubitemid 38591547)
37. Banks WA, Clever CM, Farrell CL 2000 Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice. Am J Physiol Endocrinol Metab 278:E1158-E1165 (Pubitemid 30439155)
38. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM 1997 Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94:8878-8883 (Pubitemid 27335133)
39. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis Jr HR 1997 Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99:385-390 (Pubitemid 27414794)
40. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS 2000 Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827-1832 (Pubitemid 30421764)
41. Banks WA, Lebel CR 2002 Strategies for the delivery of leptin to the CNS. J Drug Target 10:297-308 (Pubitemid 34746311)
42. Levin BE, Dunn-Meynell AA, Banks WA 2004 Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol 286:R143-R150 (Pubitemid 38055903)
43. Banks WA 2001 Enhanced leptin transport across the blood-brain barrier by α1-adrenergic agents. Brain Res 899:209-217 (Pubitemid 32324162)
44. BanksWA,Kastin AJ, Brennan JM, VallanceKL 1999 Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp Neurol 156:165-171 (Pubitemid 29152993)
45. Banks WA, Farrell CL 2003 Impaired transport of leptin across the bloodbrain barrier in obesity is acquired and reversible. Am J Physiol Endocrinol Metab 285:E10-E15 (Pubitemid 36736356)
46. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV 1996 Decreased cerebrospinal- fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161 (Pubitemid 26238099)
47. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte Jr D 1996 Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2:589-593 (Pubitemid 26151520)
48. Mantzoros C, Flier JS, Lesem MD, Brewerton TD, Jimerson DC 1997 Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin EndocrinolMetab82:1845-1851 (Pubitemid 127495198)
49. Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, Morley JE 2004 Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 53:1253-1260 (Pubitemid 38569011)
50. Kastin AJ, Akerstrom V 2001 Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin- diabetic mice. Neuroendocrinology 73:237-242 (Pubitemid 32424517)
51. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382:250-252 (Pubitemid 26251358)
52. Cheung CC, Thornton JE, Kuijper JL, Weigle DS, Clifton DK, SteinerRA1997 Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 138:855-858 (Pubitemid 27110945)
53. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI 1998 Leptin modulates the T cell immune response and reverses starvation-induced immunosuppression. Nature 394:897-901 (Pubitemid 28410912)
54. Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM 2001 Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113-1121 (Pubitemid 32995369)
55. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671 (Pubitemid 30205071)